Resumen de Investigación
Telemedicine improves glucose control in nursing home residents with diabetes.
Moderate confidence
Low bias
Última actualización 8 de julio de 2026Conclusión Clave:
This study evaluated the impact of remote insulin dose adjustment using continuous glucose monitoring (CGM) on glucose control in nursing home residents with type 2 diabetes (T2D). The intervention group showed significant improvements in glucose metrics compared to standard care.
Estudio de un Vistazo
Qué se estudió
Telemedicine-assisted insulin titration based on continuous glucose monitoring in nursing home residents with type 2 diabetes.
Participantes
Older Adults (65+)
Male, Female
with T2 Diabetes
Intervención
Telemedicine-assisted insulin titration based on CGM data, Standard care with capillary blood glucose monitoring
Resultados
Time in range (TIR), Time below range (TBR), Haemoglobin A1c (HbA1c), Mean daily insulin units
Financiamiento
No Patrocinado por la Industria
Guarda este estudio y agrega notas a tu biblioteca de investigación.
Efectos Principales
TIR increased by 10.3% in the intervention group (p = 0.010).
TBR decreased by 3.1% in the intervention group (p = 0.007).
HbA1c decreased by 9 mmol/mol in the intervention group (p = 0.028).
Mean daily insulin units decreased by 3 IU/day in the intervention group (p = 0.002).
Resumen de Evidencia
| Intervention | Outcome | Measured Change | Study Effect |
|---|---|---|---|
 Continuous glucose monitoring (Devices & Technology) |  Change in mean daily insulin units from baseline (Glycemic Control) | Decrease | Strong |
Continuous glucose monitoring (Devices & Technology) | HbA1c (Glycemic Control) | Decrease | Strong |
Continuous glucose monitoring (Devices & Technology) | Time below range (Glycemic Control) | Decrease | Strong |
Continuous glucose monitoring (Devices & Technology) | Time in range (Glycemic Control) | Increase | Strong |
Standard care with capillary blood glucose monitoring (Control) | Change in mean daily insulin units from baseline (Glycemic Control) | No Change | Unclear |
Standard care with capillary blood glucose monitoring (Control) | HbA1c (Glycemic Control) | No Change | Unclear |
Standard care with capillary blood glucose monitoring (Control) | Time below range (Glycemic Control) | No Change | Unclear |
Standard care with capillary blood glucose monitoring (Control) | Time in range (Glycemic Control) | No Change | Unclear |
Unlock Full Evidence Analysis
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
La Evidencia Sugiere
- Telemedicine-assisted insulin titration improved TIR by 10.3%.
- Intervention group showed a 3.1% reduction in TBR.
- HbA1c levels decreased by 9 mmol/mol in the intervention group.
A quién se aplica
- Nursing home residents with type 2 diabetes.
- Patients on basal-bolus insulin therapy.
- Elderly individuals requiring insulin management.
Tener en Cuenta
- Results may not apply to younger populations or those outside nursing homes.
- The study focused on a specific insulin regimen, limiting broader applicability.
- Further research is needed to confirm long-term benefits of remote monitoring.
Entre Líneas
- Limited generalizability due to specific population (nursing home residents).
- Potential biases in self-reported data.
- Short duration of the study may not capture long-term effects.
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Already have an account?
Referencia de la Revista
Ilaria D, Chiara DP, Gloria GDV, et al. Remote insulin dose adjustment based on interstitial glucose monitoring ameliorates glucose control in nursing home residents with T2D on basal‐bolus insulin therapy. Diabetes, Obesity & Metabolism. 2026;28(4):3202-3208. doi:10.1111/dom.70511
Connected Evidence
Discover how this study fits into the broader diabetes evidence landscape.
This study contributes to evidence on Insulin Delivery Systems and HbA1c, Insulin Delivery Systems and CGM Time in Range.
Relaciones de evidencia relacionadas
Explore in Evidence ArchiveThis study contributes to the evidence on the following intervention–outcome relationships.
Incluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
CGM Time in Range Evidence Hub
All studies measuring CGM Time in Range
3 studies
outcome_hubMeasures CGM Time in Range as a key outcome.
HbA1c Evidence Hub
All studies measuring HbA1c
3 studies
outcome_hubMeasures HbA1c as a key outcome.
Insulin Delivery Systems Evidence Hub
All studies on Insulin Delivery Systems
3 studies
intervention_hubContributes to Insulin Delivery Systems evidence base.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en el archivo de evidencia
Jump to pre-filtered views in the evidence archive.
All studies on Continuous glucose monitoring and HbA1c
Intervention: Continuous glucose monitoringOutcome: HbA1c
3 results
All studies on Continuous glucose monitoring and Time in range
Intervention: Continuous glucose monitoringOutcome: Time in range
3 results
All studies on Continuous glucose monitoring
Intervention: Continuous glucose monitoring
3 results
All studies measuring HbA1c
Outcome: HbA1c
3 results
All studies measuring Time in range
Outcome: Time in range
3 results
Preguntas que esta evidencia ayuda a responder
Key clinical and research questions this study contributes to.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.